Clinical Trials Directory

Trials / Unknown

UnknownNCT04228471

Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With ARDS (PReSPON)

Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With Acute Respiratory Distress Syndrome - The PReSPON Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
840 (estimated)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The potential benefits of preserved early spontaneous breathing activity during mechanical ventilation are an increased aeration of dependent lung regions, less need for sedation, improved cardiac filling, and better matching of pulmonary ventilation and perfusion and thus oxygenation. Two small randomized controlled trials (RCTs) in patients with acute respiratory distress syndrome (ARDS) reported less time on mechanical ventilation and in the intensive care unit (ICU) with preserved early spontaneous breathing activity during Airway Pressure Release Ventilation (APRV). Debate exists over the net effects of preserved early spontaneous breathing activity with regard to ventilator-associated lung injury (VALI). In fact, by taking advantage of the potential improvement in oxygenation and recruitment at lower inflation pressures associated with APRV, physicians could possibly reduce potentially harmful levels of inspired oxygen, tidal volume, and positive end-expiratory pressure (PEEP). However, spontaneous breathing during mechanical ventilation has the potential to generate less positive pleural pressures that may add to the alveolar stretch applied from the ventilator and contribute to the risk of VALI. This has led to an ongoing controversy whether an initial period of controlled mechanical ventilation with deep sedation and neuromuscular blockade or preserved early spontaneous breathing activity during mechanical ventilation is advantageous with respect to outcomes in ARDS patients. A RCT investigating the effects of early spontaneous breathing activity on mortality in moderate to severe ARDS has been highly recommended in the research agenda for intensive care medicine. The objective of this study is to evaluate the efficacy and safety of preserved spontaneous breathing activity during APRV in the early phase of moderate to severe ARDS.

Conditions

Interventions

TypeNameDescription
PROCEDUREspontaneous breathing activity during APRVAllowing spontaneous breathing activity with APRV throughout the first 48 hours.
PROCEDURENo spontaneous breathing activityNo spontaneous breathing activity will be allowed with pressure controlled ventilation throughout the first 48 hours.

Timeline

Start date
2020-02-08
Primary completion
2024-02-01
Completion
2024-07-01
First posted
2020-01-14
Last updated
2021-02-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04228471. Inclusion in this directory is not an endorsement.